Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	COVID-19: Daily Top 10 Papers

Stroke

Free Subscription Articles published in Lancet Retrieve available abstracts of 116 articles: HTML format

Single Articles

May 2021
1. KOO BK, Kang J, Park KW, Rhee TM, et al
   Aspirin versus clopidogrel for chronic maintenance monotherapy after percutaneous coronary intervention (HOST-EXAM): an investigator-initiated, prospective, randomised, open-label, multicentre trial.
   Lancet. 2021 May 14. pii: S0140-6736(21)01063.
   PubMed     Abstract available
   
   
   
2. 
   Pharmacological blood pressure lowering for primary and secondary prevention of cardiovascular disease across different levels of blood pressure: an individual participant-level data meta-analysis.
   Lancet. 2021;397:1625-1636.
   PubMed     Abstract available
   
   
   April 2021
3. VAN DER MEIJ A, Wermer MJH
   Vagus nerve stimulation: a potential new treatment for ischaemic stroke.
   Lancet. 2021;397:1520-1521.
   PubMed    
   
   
   
4. DAWSON J, Liu CY, Francisco GE, Cramer SC, et al
   Vagus nerve stimulation paired with rehabilitation for upper limb motor function after ischaemic stroke (VNS-REHAB): a randomised, blinded, pivotal, device trial.
   Lancet. 2021;397:1545-1553.
   PubMed     Abstract available
   
   
   
5. GALLI M, Benenati S, Capodanno D, Franchi F, et al
   Guided versus standard antiplatelet therapy in patients undergoing percutaneous coronary intervention: a systematic review and meta-analysis.
   Lancet. 2021;397:1470-1483.
   PubMed     Abstract available
   
   
   
6. BAYAS A, Menacher M, Christ M, Behrens L, et al
   Bilateral superior ophthalmic vein thrombosis, ischaemic stroke, and immune thrombocytopenia after ChAdOx1 nCoV-19 vaccination.
   Lancet. 2021 Apr 14. pii: S0140-6736(21)00872.
   PubMed    
   
   
   March 2021
7. TUNA MA, Rothwell PM
   Diagnosis of non-consensus transient ischaemic attacks with focal, negative, and non-progressive symptoms: population-based validation by investigation and prognosis.
   Lancet. 2021;397:902-912.
   PubMed     Abstract available
   
   
   February 2021
8. LANGLEY RE, Gilbert DC, Duong T, Clarke NW, et al
   Transdermal oestradiol for androgen suppression in prostate cancer: long-term cardiovascular outcomes from the randomised Prostate Adenocarcinoma Transcutaneous Hormone (PATCH) trial programme.
   Lancet. 2021;397:581-591.
   PubMed     Abstract available
   
   
   December 2020
9. SCOTT IU, Campochiaro PA, Newman NJ, Biousse V, et al
   Retinal vascular occlusions.
   Lancet. 2020;396:1927-1940.
   PubMed     Abstract available
   
   
   November 2020
10. GENCER B, Marston NA, Im K, Cannon CP, et al
    Efficacy and safety of lowering LDL cholesterol in older patients: a systematic review and meta-analysis of randomised controlled trials.
    Lancet. 2020;396:1637-1643.
    PubMed     Abstract available
    
    
    
11. THOMALLA G, Boutitie F, Ma H, Koga M, et al
    Intravenous alteplase for stroke with unknown time of onset guided by advanced imaging: systematic review and meta-analysis of individual patient data.
    Lancet. 2020 Nov 6. pii: S0140-6736(20)32163.
    PubMed     Abstract available
    
    
    October 2020
12. PANDIAN JD, Kalkonde Y, Sebastian IA, Felix C, et al
    Stroke systems of care in low-income and middle-income countries: challenges and opportunities.
    Lancet. 2020;396:1443-1451.
    PubMed     Abstract available
    
    
    
13. LANGHORNE P, Audebert HJ, Cadilhac DA, Kim J, et al
    Stroke systems of care in high-income countries: what is optimal?
    Lancet. 2020;396:1433-1442.
    PubMed     Abstract available
    
    
    September 2020
14. 
    NCD Countdown 2030: pathways to achieving Sustainable Development Goal target 3.4.
    Lancet. 2020;396:918-934.
    PubMed     Abstract available
    
    
    
15. MAKKAR RR, Cheng W, Waksman R, Satler LF, et al
    Self-expanding intra-annular versus commercially available transcatheter heart valves in high and extreme risk patients with severe aortic stenosis (PORTICO IDE): a randomised, controlled, non-inferiority trial.
    Lancet. 2020;396:669-683.
    PubMed     Abstract available
    
    
    August 2020
16. KIM HS, Kang J, Hwang D, Han JK, et al
    Prasugrel-based de-escalation of dual antiplatelet therapy after percutaneous coronary intervention in patients with acute coronary syndrome (HOST-REDUCE-POLYTECH-ACS): an open-label, multicentre, non-inferiority randomised trial.
    Lancet. 2020 Aug 28. pii: S0140-6736(20)31791.
    PubMed     Abstract available
    
    
    July 2020
17. CAMPBELL BCV, Khatri P
    Stroke.
    Lancet. 2020;396:129-142.
    PubMed     Abstract available
    
    
    June 2020
18. 
    Effects of a high-dose 24-h infusion of tranexamic acid on death and thromboembolic events in patients with acute gastrointestinal bleeding (HALT-IT): an international randomised, double-blind, placebo-controlled trial.
    Lancet. 2020;395:1927-1936.
    PubMed     Abstract available
    
    
    
19. ABRAMSON J, Furberg C, Jewell N, Wright JM, et al
    Questioning statin therapy for older patients.
    Lancet. 2020;395:1831-1832.
    PubMed    
    
    
    May 2020
20. HOLMES JL, Brake S, Docherty M, Lilford R, et al
    Emergency ambulance services for heart attack and stroke during UK's COVID-19 lockdown.
    Lancet. 2020 May 14. pii: S0140-6736(20)31031.
    PubMed    
    
    
    
21. CHIARITO M, Sanz-Sanchez J, Cannata F, Cao D, et al
    Monotherapy with a P2Y12 inhibitor or aspirin for secondary prevention in patients with established atherosclerosis: a systematic review and meta-analysis.
    Lancet. 2020;395:1487-1495.
    PubMed     Abstract available
    
    
    April 2020
22. GIMBEL M, Qaderdan K, Willemsen L, Hermanides R, et al
    Clopidogrel versus ticagrelor or prasugrel in patients aged 70 years or older with non-ST-elevation acute coronary syndrome (POPular AGE): the randomised, open-label, non-inferiority trial.
    Lancet. 2020;395:1374-1381.
    PubMed     Abstract available
    
    
    February 2020
23. HILL MD, Goyal M, Menon BK, Nogueira RG, et al
    Efficacy and safety of nerinetide for the treatment of acute ischaemic stroke (ESCAPE-NA1): a multicentre, double-blind, randomised controlled trial.
    Lancet. 2020 Feb 20. pii: S0140-6736(20)30258.
    PubMed     Abstract available
    
    
    
24. HANKEY GJ
    Nerinetide before reperfusion in acute ischaemic stroke: deja vu or new insights?
    Lancet. 2020 Feb 20. pii: S0140-6736(20)30316.
    PubMed    
    
    
    
25. NEGRINI S, Arienti C, Kiekens C
    Usual care: the big but unmanaged problem of rehabilitation evidence.
    Lancet. 2020;395:337.
    PubMed    
    
    
    December 2019
26. HOLM NR, Makikallio T, Lindsay MM, Spence MS, et al
    Percutaneous coronary angioplasty versus coronary artery bypass grafting in the treatment of unprotected left main stenosis: updated 5-year outcomes from the randomised, non-inferiority NOBLE trial.
    Lancet. 2019 Dec 23. pii: S0140-6736(19)32972.
    PubMed     Abstract available
    
    
    
27. BRUNNER FJ, Waldeyer C, Ojeda F, Salomaa V, et al
    Application of non-HDL cholesterol for population-based cardiovascular risk stratification: results from the Multinational Cardiovascular Risk Consortium.
    Lancet. 2019 Dec 3. pii: S0140-6736(19)32519.
    PubMed     Abstract available
    
    
    October 2019
28. THE LANCET
    Don't be the one: individual responsibility in stroke prevention.
    Lancet. 2019;394:1482.
    PubMed    
    
    
    
29. SUCHARD MA, Schuemie MJ, Krumholz HM, You SC, et al
    Comprehensive comparative effectiveness and safety of first-line antihypertensive drug classes: a systematic, multinational, large-scale analysis.
    Lancet. 2019 Oct 24. pii: S0140-6736(19)32317.
    PubMed     Abstract available
    
    
    
30. COUTTS SB
    Preventing unnecessary disability after stroke in Scotland.
    Lancet. 2019;394:1225-1226.
    PubMed    
    
    
    September 2019
31. ZHOU M, Wang H, Zeng X, Yin P, et al
    Mortality, morbidity, and risk factors in China and its provinces, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017.
    Lancet. 2019;394:1145-1158.
    PubMed     Abstract available
    
    
    
32. VRANCKX P, Valgimigli M, Eckardt L, Tijssen J, et al
    Edoxaban-based versus vitamin K antagonist-based antithrombotic regimen after successful coronary stenting in patients with atrial fibrillation (ENTRUST-AF PCI): a randomised, open-label, phase 3b trial.
    Lancet. 2019 Sep 2. pii: S0140-6736(19)31872.
    PubMed     Abstract available
    
    
    August 2019
33. BHATT DL, Steg PG, Mehta SR, Leiter LA, et al
    Ticagrelor in patients with diabetes and stable coronary artery disease with a history of previous percutaneous coronary intervention (THEMIS-PCI): a phase 3, placebo-controlled, randomised trial.
    Lancet. 2019 Aug 30. pii: S0140-6736(19)31887.
    PubMed     Abstract available
    
    
    
34. ANDERSON CS, Bath PM
    Blood pressure reduction and intravenous thrombolysis - Authors' reply.
    Lancet. 2019;394:e25.
    PubMed    
    
    
    
35. KRUYT ND, Roos YB, Nederkoorn PJ
    Blood pressure reduction and intravenous thrombolysis.
    Lancet. 2019;394:e24.
    PubMed    
    
    
    
36. VLISIDES PE, Avidan MS, Mashour GA
    Uncovering covert stroke in surgical patients.
    Lancet. 2019 Aug 14. pii: S0140-6736(19)31770.
    PubMed    
    
    
    
37. 
    Perioperative covert stroke in patients undergoing non-cardiac surgery (NeuroVISION): a prospective cohort study.
    Lancet. 2019 Aug 14. pii: S0140-6736(19)31795.
    PubMed     Abstract available
    
    
    July 2019
38. SANDSET EC, Ford GA
    Sphenopalatine ganglion stimulation after stroke, promising but not yet ready for adoption.
    Lancet. 2019;394:189-190.
    PubMed    
    
    
    June 2019
39. GERSTEIN HC, Colhoun HM, Dagenais GR, Diaz R, et al
    Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial.
    Lancet. 2019 Jun 7. pii: S0140-6736(19)31149.
    PubMed     Abstract available
    
    
    May 2019
40. BORNSTEIN NM, Saver JL, Diener HC, Gorelick PB, et al
    An injectable implant to stimulate the sphenopalatine ganglion for treatment of acute ischaemic stroke up to 24 h from onset (ImpACT-24B): an international, randomised, double-blind, sham-controlled, pivotal trial.
    Lancet. 2019 May 23. pii: S0140-6736(19)31192.
    PubMed     Abstract available
    
    
    
41. CAMPBELL BCV, Ma H, Ringleb PA, Parsons MW, et al
    Extending thrombolysis to 4.5-9 h and wake-up stroke using perfusion imaging: a systematic review and meta-analysis of individual patient data.
    Lancet. 2019 May 21. pii: S0140-6736(19)31053.
    PubMed     Abstract available
    
    
    
42. ZIAI WC, Tsiskaridze A
    Restarting antiplatelet therapy after intracerebral haemorrhage.
    Lancet. 2019 May 21. pii: S0140-6736(19)31094.
    PubMed    
    
    
    
43. BERNHARDT J, Mehrholz J
    Robotic-assisted training after stroke: RATULS advances science.
    Lancet. 2019 May 21. pii: S0140-6736(19)31156.
    PubMed    
    
    
    
44. COUTTS SB, Menon BK
    Late thrombolysis for stroke works, but how do we do it?
    Lancet. 2019 May 21. pii: S0140-6736(19)31095.
    PubMed    
    
    
    
45. 
    Effects of antiplatelet therapy after stroke due to intracerebral haemorrhage (RESTART): a randomised, open-label trial.
    Lancet. 2019 May 21. pii: S0140-6736(19)30840.
    PubMed     Abstract available
    
    
    April 2019
46. MCCALL B
    Alemtuzumab to be restricted pending review, says EMA.
    Lancet. 2019;393:1683.
    PubMed    
    
    
    
47. MILLWOOD IY, Walters RG, Mei XW, Guo Y, et al
    Conventional and genetic evidence on alcohol and vascular disease aetiology: a prospective study of 500 000 men and women in China.
    Lancet. 2019 Apr 4. pii: S0140-6736(18)31772.
    PubMed     Abstract available
    
    
    March 2019
48. TURK AS 3RD, Siddiqui A, Fifi JT, De Leacy RA, et al
    Aspiration thrombectomy versus stent retriever thrombectomy as first-line approach for large vessel occlusion (COMPASS): a multicentre, randomised, open label, blinded outcome, non-inferiority trial.
    Lancet. 2019;393:998-1008.
    PubMed     Abstract available
    
    
    
49. MENON BK, Goyal M
    Thrombus aspiration or retrieval in acute ischaemic stroke.
    Lancet. 2019;393:962-963.
    PubMed    
    
    
    February 2019
50. SANDSET EC, Fischer U
    Blood pressure lowering in acute ischaemic stroke thrombolysis.
    Lancet. 2019 Feb 6. pii: S0140-6736(19)30196.
    PubMed    
    
    
    
51. HANLEY DF, Thompson RE, Rosenblum M, Yenokyan G, et al
    Efficacy and safety of minimally invasive surgery with thrombolysis in intracerebral haemorrhage evacuation (MISTIE III): a randomised, controlled, open-label, blinded endpoint phase 3 trial.
    Lancet. 2019 Feb 6. pii: S0140-6736(19)30195.
    PubMed     Abstract available
    
    
    
52. SALMAN RA, Klijn CJM, Selim M
    Minimally invasive surgery plus alteplase for intracerebral haemorrhage.
    Lancet. 2019 Feb 6. pii: S0140-6736(19)30309.
    PubMed    
    
    
    
53. ANDERSON CS, Huang Y, Lindley RI, Chen X, et al
    Intensive blood pressure reduction with intravenous thrombolysis therapy for acute ischaemic stroke (ENCHANTED): an international, randomised, open-label, blinded-endpoint, phase 3 trial.
    Lancet. 2019 Feb 6. pii: S0140-6736(19)30038.
    PubMed     Abstract available
    
    
    
54. 
    Prehospital transdermal glyceryl trinitrate in patients with ultra-acute presumed stroke (RIGHT-2): an ambulance-based, randomised, sham-controlled, blinded, phase 3 trial.
    Lancet. 2019 Feb 5. pii: S0140-6736(19)30194.
    PubMed     Abstract available
    
    
    
55. JOHNSTON KC, Durkalski-Mauldin VL
    Considering prehospital stroke trials: did RIGHT-2 get it right?
    Lancet. 2019 Feb 5. pii: S0140-6736(19)30276.
    PubMed    
    
    
    December 2018
56. 
    Effects of fluoxetine on functional outcomes after acute stroke (FOCUS): a pragmatic, double-blind, randomised, controlled trial.
    Lancet. 2018 Dec 4. pii: S0140-6736(18)32823.
    PubMed     Abstract available
    
    
    
57. VAN DER WORP HB
    Fluoxetine and recovery after stroke.
    Lancet. 2018 Dec 4. pii: S0140-6736(18)32983.
    PubMed    
    
    
    October 2018
58. CHILAMKURTHY S, Ghosh R, Tanamala S, Biviji M, et al
    Deep learning algorithms for detection of critical findings in head CT scans: a retrospective study.
    Lancet. 2018 Oct 11. pii: S0140-6736(18)31645.
    PubMed     Abstract available
    
    
    
59. ZERNA C, Thomalla G, Campbell BCV, Rha JH, et al
    Current practice and future directions in the diagnosis and acute treatment of ischaemic stroke.
    Lancet. 2018;392:1247-1256.
    PubMed     Abstract available
    
    
    
60. PANDIAN JD, Gall SL, Kate MP, Silva GS, et al
    Prevention of stroke: a global perspective.
    Lancet. 2018;392:1269-1278.
    PubMed     Abstract available
    
    
    
61. THE LANCET
    21st century management and prevention of stroke.
    Lancet. 2018;392:1167.
    PubMed    
    
    
    
62. HERNANDEZ AF, Green JB, Janmohamed S, D'Agostino RB Sr, et al
    Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial.
    Lancet. 2018 Oct 1. pii: S0140-6736(18)32261.
    PubMed     Abstract available
    
    
    September 2018
63. BHATT DL
    Aspirin-still the GLOBAL LEADER in antiplatelet therapy.
    Lancet. 2018;392:896-897.
    PubMed    
    
    
    August 2018
64. VALGIMIGLI M, Frigoli E, Leonardi S, Vranckx P, et al
    Radial versus femoral access and bivalirudin versus unfractionated heparin in invasively managed patients with acute coronary syndrome (MATRIX): final 1-year results of a multicentre, randomised controlled trial.
    Lancet. 2018 Aug 24. pii: S0140-6736(18)31714.
    PubMed     Abstract available
    
    
    
65. GAZIANO JM, Brotons C, Coppolecchia R, Cricelli C, et al
    Use of aspirin to reduce risk of initial vascular events in patients at moderate risk of cardiovascular disease (ARRIVE): a randomised, double-blind, placebo-controlled trial.
    Lancet. 2018 Aug 24. pii: S0140-6736(18)31924.
    PubMed     Abstract available
    
    
    
66. ROTHWELL PM, Cook NR, Gaziano JM, Price JF, et al
    Effects of aspirin on risks of vascular events and cancer according to bodyweight and dose: analysis of individual patient data from randomised trials.
    Lancet. 2018;392:387-399.
    PubMed     Abstract available
    
    
    June 2018
67. PATEL T, Tesfaldet B, Chowdhury I, Kettermann A, et al
    Endpoints in diabetes cardiovascular outcome trials.
    Lancet. 2018;391:2412.
    PubMed    
    
    
    
68. DEVEREAUX PJ, Duceppe E, Guyatt G, Tandon V, et al
    Dabigatran in patients with myocardial injury after non-cardiac surgery (MANAGE): an international, randomised, placebo-controlled trial.
    Lancet. 2018;391:2325-2334.
    PubMed     Abstract available
    
    
    May 2018
69. LANGHORNE P, O'Donnell MJ, Chin SL, Zhang H, et al
    Practice patterns and outcomes after stroke across countries at different economic levels (INTERSTROKE): an international observational study.
    Lancet. 2018;391:2019-2027.
    PubMed     Abstract available
    
    
    
70. BRAININ M
    Stroke units around the world: the success story continues.
    Lancet. 2018;391:1970-1971.
    PubMed    
    
    
    
71. SPRIGG N, Flaherty K, Appleton JP, Salman RA, et al
    Tranexamic acid for hyperacute primary IntraCerebral Haemorrhage (TICH-2): an international randomised, placebo-controlled, phase 3 superiority trial.
    Lancet. 2018 May 15. pii: S0140-6736(18)31033.
    PubMed     Abstract available
    
    
    February 2018
72. ABUKARESH A, Al-Abadlah R, Bottcher B, El-Essi K, et al
    Ischaemic stroke management at Al-Shifa Hospital in the Gaza Strip: a clinical audit.
    Lancet. 2018;391 Suppl 2:S7.
    PubMed     Abstract available
    
    
    
73. ALKHATIB MN, Abd-Alghafoor T, Elmassry A, Albarqouni L, et al
    Management of acute ischaemic stroke at Nasser Hospital, Gaza Strip: a clinical audit.
    Lancet. 2018;391 Suppl 2:S28.
    PubMed     Abstract available
    
    
    
74. THE LANCET
    Stroke-acting FAST at all ages.
    Lancet. 2018;391:514.
    PubMed    
    
    
    January 2018
75. ANAND SS, Bosch J, Eikelboom JW, Connolly SJ, et al
    Rivaroxaban with or without aspirin in patients with stable peripheral or carotid artery disease: an international, randomised, double-blind, placebo-controlled trial.
    Lancet. 2018;391:219-229.
    PubMed     Abstract available
    
    
    December 2017
76. AMARENCO P
    Learning from TARDIS: time for more focused trials in stroke prevention.
    Lancet. 2017 Dec 20. pii: S0140-6736(17)33309.
    PubMed    
    
    
    
77. BATH PM, Woodhouse LJ, Appleton JP, Beridze M, et al
    Antiplatelet therapy with aspirin, clopidogrel, and dipyridamole versus clopidogrel alone or aspirin and dipyridamole in patients with acute cerebral ischaemia (TARDIS): a randomised, open-label, phase 3 superiority trial.
    Lancet. 2017 Dec 20. pii: S0140-6736(17)32849.
    PubMed     Abstract available
    
    
    November 2017
78. CONNOLLY SJ, Eikelboom JW, Bosch J, Dagenais G, et al
    Rivaroxaban with or without aspirin in patients with stable coronary artery disease: an international, randomised, double-blind, placebo-controlled trial.
    Lancet. 2017 Nov 10. pii: S0140-6736(17)32458.
    PubMed     Abstract available
    
    
    October 2017
79. WOOD D, Eisele JL
    A global coalition for the fight against heart disease and stroke.
    Lancet. 2017 Oct 16. pii: S0140-6736(17)32676.
    PubMed    
    
    
    August 2017
80. SIBBING D, Aradi D, Jacobshagen C, Gross L, et al
    Guided de-escalation of antiplatelet treatment in patients with acute coronary syndrome undergoing percutaneous coronary intervention (TROPICAL-ACS): a randomised, open-label, multicentre trial.
    Lancet. 2017 Aug 25. pii: S0140-6736(17)32155.
    PubMed     Abstract available
    
    
    
81. VINEREANU D, Lopes RD, Bahit MC, Xavier D, et al
    A multifaceted intervention to improve treatment with oral anticoagulants in atrial fibrillation (IMPACT-AF): an international, cluster-randomised trial.
    Lancet. 2017 Aug 25. pii: S0140-6736(17)32165.
    PubMed     Abstract available
    
    
    
82. JINATONGTHAI P, Kongwatcharapong J, Foo CY, Phrommintikul A, et al
    Comparative efficacy and safety of reperfusion therapy with fibrinolytic agents in patients with ST-segment elevation myocardial infarction: a systematic review and network meta-analysis.
    Lancet. 2017;390:747-759.
    PubMed     Abstract available
    
    
    July 2017
83. SAKAMOTO R, Higuchi A, Tsuda K, Tanimoto T, et al
    Intensive speech and language therapy after stroke.
    Lancet. 2017;390:228.
    PubMed    
    
    
    
84. BREITENSTEIN C, Martus P, Willmes K, Ziegler W, et al
    Intensive speech and language therapy after stroke - Authors' reply.
    Lancet. 2017;390:228-229.
    PubMed    
    
    
    
85. WARE RE, de Montalembert M, Tshilolo L, Abboud MR, et al
    Sickle cell disease.
    Lancet. 2017;390:311-323.
    PubMed     Abstract available
    
    
    June 2017
86. 
    Family-led rehabilitation after stroke in India (ATTEND): a randomised controlled trial.
    Lancet. 2017 Jun 27. pii: S0140-6736(17)31447.
    PubMed     Abstract available
    
    
    
87. LI L, Geraghty OC, Mehta Z, Rothwell PM, et al
    Age-specific risks, severity, time course, and outcome of bleeding on long-term antiplatelet treatment after vascular events: a population-based cohort study.
    Lancet. 2017 Jun 13. pii: S0140-6736(17)30770.
    PubMed     Abstract available
    
    
    April 2017
88. KIRCHHOF P
    The future of atrial fibrillation management: integrated care and stratified therapy.
    Lancet. 2017 Apr 28. pii: S0140-6736(17)31072.
    PubMed     Abstract available
    
    
    
89. HACHINSKI V
    Stoop to conquer: preventing stroke and dementia together.
    Lancet. 2017;389:1518.
    PubMed    
    
    
    March 2017
90. HEALEY JS, Oldgren J
    Risk of mortality and stroke after atrial fibrillation - Authors' reply.
    Lancet. 2017;389:907.
    PubMed    
    
    
    
91. HUO Z
    Risk of mortality and stroke after atrial fibrillation.
    Lancet. 2017;389:907.
    PubMed    
    
    
    
92. MIHAS C, Mariolis A, Letsas KP, Kantzanou M, et al
    Risk of mortality and stroke after atrial fibrillation.
    Lancet. 2017;389:906.
    PubMed    
    
    
    February 2017
93. BREITENSTEIN C, Grewe T, Floel A, Ziegler W, et al
    Intensive speech and language therapy in patients with chronic aphasia after stroke: a randomised, open-label, blinded-endpoint, controlled trial in a health-care setting.
    Lancet. 2017 Feb 27. pii: S0140-6736(17)30067.
    PubMed     Abstract available
    
    
    January 2017
94. HANLEY DF, Lane K, McBee N, Ziai W, et al
    Thrombolytic removal of intraventricular haemorrhage in treatment of severe stroke: results of the randomised, multicentre, multiregion, placebo-controlled CLEAR III trial.
    Lancet. 2017 Jan 9. pii: S0140-6736(16)32410.
    PubMed     Abstract available
    
    
    
95. RABINSTEIN AA
    Intracerebral haemorrhage: no good treatment but treatment helps.
    Lancet. 2017 Jan 9. pii: S0140-6736(17)30002.
    PubMed    
    
    
    
96. O'DONNELL M, Yusuf S
    The INTERSTROKE study on risk factors for stroke - Authors' reply.
    Lancet. 2017;389:36.
    PubMed    
    
    
    
97. ZENG X, Deng A, Ding Y
    The INTERSTROKE study on risk factors for stroke.
    Lancet. 2017;389:35.
    PubMed    
    
    
    November 2016
98. COLLINS R, Reith C, Emberson J, Armitage J, et al
    Interpretation of the evidence for the efficacy and safety of statin therapy.
    Lancet. 2016;388:2532-2561.
    PubMed     Abstract available
    
    
    October 2016
99. MAKIKALLIO T, Holm NR, Lindsay M, Spence MS, et al
    Percutaneous coronary angioplasty versus coronary artery bypass grafting in treatment of unprotected left main stenosis (NOBLE): a prospective, randomised, open-label, non-inferiority trial.
    Lancet. 2016 Oct 28. pii: S0140-6736(16)32052.
    PubMed     Abstract available
    
    
    
100. CHARIDIMOU A
     The ABC risk score for patients with atrial fibrillation.
     Lancet. 2016;388:1979.
     PubMed    
     
     
     
101. PROVIDENCIA R, Lambiase PD
     The ABC risk score for patients with atrial fibrillation.
     Lancet. 2016;388:1979-1980.
     PubMed    
     
     
     
102. GUAN WJ, Zheng XY, Chung KF, Zhong NS, et al
     Impact of air pollution on the burden of chronic respiratory diseases in China: time for urgent action.
     Lancet. 2016;388:1939-1951.
     PubMed     Abstract available
     
     
     
103. SHAKIR R, Davis S, Norrving B, Grisold W, et al
     Revising the ICD: stroke is a brain disease.
     Lancet. 2016 Oct 14. pii: S0140-6736(16)31850.
     PubMed    
     
     
     September 2016
104. HANKEY GJ
     Stroke.
     Lancet. 2016 Sep 13. pii: S0140-6736(16)30962.
     PubMed     Abstract available
     
     
     August 2016
105. GOETTE A, Merino JL, Ezekowitz MD, Zamoryakhin D, et al
     Edoxaban versus enoxaparin-warfarin in patients undergoing cardioversion of atrial fibrillation (ENSURE-AF): a randomised, open-label, phase 3b trial.
     Lancet. 2016 Aug 26. pii: S0140-6736(16)31474.
     PubMed     Abstract available
     
     
     
106. VIDAL-PETIOT E, Ford I, Greenlaw N, Ferrari R, et al
     Cardiovascular event rates and mortality according to achieved systolic and diastolic blood pressure in patients with stable coronary artery disease: an international cohort study.
     Lancet. 2016 Aug 26. pii: S0140-6736(16)31326.
     PubMed     Abstract available
     
     
     
107. BAGOT KL, Cadilhac DA, Hand PJ, Vu M, et al
     Telemedicine expedites access to optimal acute stroke care.
     Lancet. 2016;388:757-758.
     PubMed    
     
     
     
108. THE LANCET
     Atrial fibrillation and stroke: unrecognised and undertreated.
     Lancet. 2016;388:731.
     PubMed    
     
     
     
109. PICCINI JP, Fauchier L
     Rhythm control in atrial fibrillation.
     Lancet. 2016;388:829-840.
     PubMed     Abstract available
     
     
     
110. FREEDMAN B, Potpara TS, Lip GY
     Stroke prevention in atrial fibrillation.
     Lancet. 2016;388:806-817.
     PubMed     Abstract available
     
     
     
111. HEALEY JS, Oldgren J, Ezekowitz M, Zhu J, et al
     Occurrence of death and stroke in patients in 47 countries 1 year after presenting with atrial fibrillation: a cohort study.
     Lancet. 2016 Aug 8. pii: S0140-6736(16)30968.
     PubMed     Abstract available
     
     
     
112. BORLONGAN CV
     Age of PISCES: stem-cell clinical trials in stroke.
     Lancet. 2016 Aug 3. pii: S0140-6736(16)31259.
     PubMed    
     
     
     
113. KALLADKA D, Sinden J, Pollock K, Haig C, et al
     Human neural stem cells in patients with chronic ischaemic stroke (PISCES): a phase 1, first-in-man study.
     Lancet. 2016 Aug 3. pii: S0140-6736(16)30513.
     PubMed     Abstract available
     
     
     July 2016
114. SNYDER A
     Philip Majerus.
     Lancet. 2016;388:458.
     PubMed    
     
     
     
115. FEIGIN VL, Krishnamurthi R
     Stroke is largely preventable across the globe: where to next?
     Lancet. 2016 Jul 15. pii: S0140-6736(16)30679.
     PubMed    
     
     
     
116. O'DONNELL MJ, Chin SL, Rangarajan S, Xavier D, et al
     Global and regional effects of potentially modifiable risk factors associated with acute stroke in 32 countries (INTERSTROKE): a case-control study.
     Lancet. 2016 Jul 15. pii: S0140-6736(16)30506.
     PubMed     Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Stroke is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: